FY2026 EPS Forecast for SBC Medical Group Lowered by Analyst

Key Points

• Zacks Research lowered SBC Medical Group’s FY2026 EPS forecast to $0.42 from $0.49, below the current analyst consensus of $0.48.
• SBC’s latest quarterly EPS of $0.10 missed expectations of $0.12, although revenue of $49.19 million exceeded the $45.37 million consensus estimate.
• Analyst sentiment remains mixed, with two Buy ratings and one Sell rating; shares opened at $3.68, while the average price target stands at $8.50.

SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Free Report) - Equities research analysts at Zacks Research lowered their FY2026 earnings per share (EPS) estimates for shares of SBC Medical Group in a research note issued to investors on Wednesday, August 19th. Zacks Research analyst M. Marin now anticipates that the company will post earnings per share of $0.42 for the year, down from their prior forecast of $0.49. The consensus estimate for SBC Medical Group's current full-year earnings is $0.48 per share.

Several other research firms have also recently commented on SBC. Wall Street Zen upgraded shares of SBC Medical Group from a "hold" rating to a "buy" rating in a report on Saturday, August 15th. Weiss Ratings restated a "sell (d+)" rating on shares of SBC Medical Group in a report on Wednesday. Finally, BTIG Research reaffirmed a "buy" rating and set a $8.00 price objective on shares of SBC Medical Group in a research report on Thursday, August 13th. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $8.50.

SBC Medical Group Stock Down 4.9%

Shares of NASDAQ:SBC opened at $3.68 on Friday. The firm's 50 day moving average price is $3.14 and its 200 day moving average price is $3.54. The stock has a market cap of $377.49 million, a price-to-earnings ratio of 7.83 and a beta of 0.59. SBC Medical Group has a fifty-two week low of $2.78 and a fifty-two week high of $5.07. The company has a quick ratio of 3.27, a current ratio of 3.31 and a debt-to-equity ratio of 0.09.

SBC Medical Group (NASDAQ:SBC - Get Free Report) last announced its quarterly earnings data on Thursday, August 13th. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.02). SBC Medical Group had a net margin of 27.99% and a return on equity of 18.47%. The company had revenue of $49.19 million during the quarter, compared to analysts' expectations of $45.37 million.

Hedge Funds Weigh In On SBC Medical Group

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Williams & Novak LLC raised its holdings in SBC Medical Group by 31.2% during the second quarter. Williams & Novak LLC now owns 18,686 shares of the company's stock worth $58,000 after purchasing an additional 4,449 shares in the last quarter. Wells Fargo & Company MN grew its position in shares of SBC Medical Group by 195.1% in the 4th quarter. Wells Fargo & Company MN now owns 12,626 shares of the company's stock valued at $54,000 after buying an additional 8,348 shares during the last quarter. Russell Investments Group Ltd. grew its position in shares of SBC Medical Group by 292.0% in the 4th quarter. Russell Investments Group Ltd. now owns 11,775 shares of the company's stock valued at $51,000 after buying an additional 8,771 shares during the last quarter. Barclays PLC raised its stake in SBC Medical Group by 123.7% during the 4th quarter. Barclays PLC now owns 17,779 shares of the company's stock worth $77,000 after acquiring an additional 9,831 shares in the last quarter. Finally, Bank of New York Mellon Corp purchased a new position in shares of SBC Medical Group during the first quarter worth about $43,000. 60.82% of the stock is owned by institutional investors and hedge funds.

SBC Medical Group Company Profile

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company's primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source